Financhill
Sell
25

MRK Quote, Financials, Valuation and Earnings

Last price:
$98.17
Seasonality move :
1.97%
Day range:
$97.90 - $99.68
52-week range:
$94.48 - $134.63
Dividend yield:
3.18%
P/E ratio:
20.56x
P/S ratio:
3.95x
P/B ratio:
5.57x
Volume:
29.2M
Avg. volume:
13.5M
1-year change:
-6.94%
Market cap:
$248B
Revenue:
$60.1B
EPS (TTM):
$4.77
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $39.1B $41.5B $48.7B $59.3B $60.1B
Revenue Growth (YoY) -7.5% 6.13% 17.31% 21.72% 1.4%
 
Cost of Revenues $12B $13.6B $13.6B $17.4B $16.1B
Gross Profit $27.1B $27.9B $35.1B $41.9B $44B
Gross Profit Margin 69.29% 67.2% 72.02% 70.63% 73.18%
 
R&D Expenses $9.7B $13.4B $12.2B $13.5B $30.5B
Selling, General & Admin $9.5B $9B $9.6B $10B $10.5B
Other Inc / (Exp) -$136M $1.1B $1.5B -$1B -$284M
Operating Expenses $19.2B $22.4B $21.9B $23.6B $41B
Operating Income $7.9B $5.5B $13.2B $18.3B $3B
 
Net Interest Expenses $619M $772M $770M $805M $781M
EBT. Incl. Unusual Items $7.2B $5.9B $13.9B $16.4B $1.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.6B $1.3B $1.5B $1.9B $1.5B
Net Income to Company $5.6B $4.5B $12.4B $14.5B $377M
 
Minority Interest in Earnings $4.2B $2.5B $691M -$7M -$12M
Net Income to Common Excl Extra Items $9.8B $7.1B $13B $14.5B $365M
 
Basic EPS (Cont. Ops) $3.84 $2.79 $5.16 $5.73 $0.14
Diluted EPS (Cont. Ops) $3.81 $2.78 $5.14 $5.71 $0.14
Weighted Average Basic Share $2.6B $2.5B $2.5B $2.5B $2.5B
Weighted Average Diluted Share $2.6B $2.5B $2.5B $2.5B $2.5B
 
EBITDA $11.4B $10.2B $17.9B $21.3B $6.9B
EBIT $8.1B $6.7B $14.7B $17.4B $3B
 
Revenue (Reported) $39.1B $41.5B $48.7B $59.3B $60.1B
Operating Income (Reported) $7.9B $5.5B $13.2B $18.3B $3B
Operating Income (Adjusted) $8.1B $6.7B $14.7B $17.4B $3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $10.9B $13.2B $15B $16B $16.7B
Revenue Growth (YoY) -11.84% 20.36% 13.72% 6.71% 4.35%
 
Cost of Revenues $3B $3.5B $3.9B $4.3B $4.1B
Gross Profit $7.9B $9.7B $11B $11.7B $12.6B
Gross Profit Margin 72.43% 73.77% 73.7% 73.29% 75.51%
 
R&D Expenses $3.3B $2.4B $4.4B $3.3B $5.9B
Selling, General & Admin $2.1B $2.3B $2.5B $2.5B $2.7B
Other Inc / (Exp) $393M $532M -$319M -$8M $309M
Operating Expenses $5.4B $4.8B $6.9B $5.8B $8.6B
Operating Income $2.5B $4.9B $4.1B $5.9B $4B
 
Net Interest Expenses $194M $189M $204M $244M $203M
EBT. Incl. Unusual Items $2.7B $5.3B $3.6B $5.6B $4.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $380M $695M $330M $870M $929M
Net Income to Company $2.3B $4.6B $3.3B $4.8B $3.2B
 
Minority Interest in Earnings $615M -$4M -$5M -$5M -$4M
Net Income to Common Excl Extra Items $2.9B $4.6B $3.2B $4.7B $3.2B
 
Basic EPS (Cont. Ops) $1.16 $1.81 $1.28 $1.87 $1.25
Diluted EPS (Cont. Ops) $1.16 $1.80 $1.28 $1.86 $1.24
Weighted Average Basic Share $2.5B $2.5B $2.5B $2.5B $2.5B
Weighted Average Diluted Share $2.5B $2.5B $2.5B $2.5B $2.5B
 
EBITDA $3.7B $6.2B $4.8B $7B $5.6B
EBIT $2.9B $5.5B $3.8B $5.9B $4.4B
 
Revenue (Reported) $10.9B $13.2B $15B $16B $16.7B
Operating Income (Reported) $2.5B $4.9B $4.1B $5.9B $4B
Operating Income (Adjusted) $2.9B $5.5B $3.8B $5.9B $4.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $36.5B $46.1B $59B $59.3B $63.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $10.6B $14.8B $17.4B $16.1B $15.3B
Gross Profit $25.8B $31.3B $41.6B $43.2B $47.9B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $10B $15B $12.8B $24.7B $23B
Selling, General & Admin $8.4B $9.4B $10.2B $10.4B $10.8B
Other Inc / (Exp) $1.2B $1.2B -$839M -$23M $475M
Operating Expenses $18.5B $24.4B $23B $35.1B $33.7B
Operating Income $7.4B $7B $18.5B $8.2B $14.2B
 
Net Interest Expenses $746M $767M $865M $682M $914M
EBT. Incl. Unusual Items $7.8B $7.4B $16.8B $7.4B $13.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.7B $1.5B $1.5B $2.8B $1.6B
Net Income to Company $5.3B $5.9B $15.3B $4.6B $12.2B
 
Minority Interest in Earnings $5.4B $1.3B -$73M -$13M -$15M
Net Income to Common Excl Extra Items $11.5B $7.2B $15.3B $4.6B $12.1B
 
Basic EPS (Cont. Ops) $4.55 $2.85 $6.03 $1.82 $4.80
Diluted EPS (Cont. Ops) $4.52 $2.83 $6.01 $1.80 $4.77
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $11.8B $11.5B $21.6B $12.3B $19.2B
EBIT $8.6B $8.2B $17.8B $8.5B $15B
 
Revenue (Reported) $36.5B $46.1B $59B $59.3B $63.2B
Operating Income (Reported) $7.4B $7B $18.5B $8.2B $14.2B
Operating Income (Adjusted) $8.6B $8.2B $17.8B $8.5B $15B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $32.3B $35.2B $45.5B $45.5B $48.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $9.1B $9.8B $13.5B $12.2B $11.4B
Gross Profit $23.3B $25.4B $31.9B $33.3B $37.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $7.6B $9.2B $9.8B $20.9B $13.4B
Selling, General & Admin $6.7B $6.8B $7.4B $7.7B $8B
Other Inc / (Exp) $937M $1.1B -$1.2B -$189M $568M
Operating Expenses $14.3B $16B $17.1B $28.6B $21.3B
Operating Income $8.9B $9.4B $14.8B $4.7B $15.9B
 
Net Interest Expenses $576M $571M $665M $542M $674M
EBT. Incl. Unusual Items $9.3B $10B $12.9B $3.9B $15.8B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.4B $1.4B $1.4B $2.3B $2.4B
Net Income to Company $7.1B $8.5B $11.5B $1.6B $13.4B
 
Minority Interest in Earnings $1.3B $757M -$7M -$12M -$15M
Net Income to Common Excl Extra Items $9.2B $9.3B $11.5B $1.6B $13.4B
 
Basic EPS (Cont. Ops) $3.62 $3.68 $4.54 $0.63 $5.28
Diluted EPS (Cont. Ops) $3.60 $3.66 $4.53 $0.62 $5.25
Weighted Average Basic Share $7.6B $7.6B $7.6B $7.6B $7.6B
Weighted Average Diluted Share $7.6B $7.6B $7.6B $7.6B $7.6B
 
EBITDA $12.5B $12.9B $16.7B $7.7B $20B
EBIT $9.9B $10.6B $13.7B $4.8B $16.7B
 
Revenue (Reported) $32.3B $35.2B $45.5B $45.5B $48.5B
Operating Income (Reported) $8.9B $9.4B $14.8B $4.7B $15.9B
Operating Income (Adjusted) $9.9B $10.6B $13.7B $4.8B $16.7B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $9.7B $8.1B $8.1B $12.7B $6.8B
Short Term Investments $774M -- -- $498M $252M
Accounts Receivable, Net $6.8B $6.8B $9.2B $9.5B $10.3B
Inventory $6B $5.6B $6B $5.9B $6.4B
Prepaid Expenses -- -- -- -- --
Other Current Assets $4.3B $4.7B $7B $7.2B $8.4B
Total Current Assets $27.5B $27.8B $30.3B $35.7B $32.2B
 
Property Plant And Equipment $15.1B $17B $19.3B $21.4B $23.1B
Long-Term Investments $1.5B $785M $370M $1B $252M
Goodwill $19.4B $18.9B $21.3B $21.2B $21.2B
Other Intangibles $14.2B $14.1B $22.9B $20.3B $18B
Other Long-Term Assets $6.8B $13.1B $11.6B $9.5B $12B
Total Assets $84.4B $91.6B $105.7B $109.2B $106.7B
 
Accounts Payable $3.7B $4.3B $4.6B $4.3B $3.9B
Accrued Expenses $12.5B $12.2B $13.9B $14.2B $15.8B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- $1.1B -- -- --
Total Current Liabilities $22.2B $27.3B $23.9B $24.2B $25.7B
 
Long-Term Debt $22.7B $25.4B $30.7B $28.7B $33.7B
Capital Leases -- -- -- -- --
Total Liabilities $58.4B $66.2B $67.4B $63.1B $69B
 
Common Stock $1.8B $1.8B $1.8B $1.8B $1.8B
Other Common Equity Adj -$6.2B -$6.6B -$4.4B -$4.8B -$5.2B
Common Equity $25.9B $25.3B $38.2B $46B $37.6B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $94M $87M $73M $67M $54M
Total Equity $26B $25.4B $38.3B $46.1B $37.6B
 
Total Liabilities and Equity $84.4B $91.6B $105.7B $109.2B $106.7B
Cash and Short Terms $10.5B $8.1B $8.1B $13.2B $7.1B
Total Debt $26.3B $31.8B $33.1B $30.7B $35.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $7.4B $10B $11.1B $8.6B $14.6B
Short Term Investments -- -- $103M $168M --
Accounts Receivable, Net $8.4B $8.6B $9.5B $10.4B $11.4B
Inventory $8.2B $8B $5.6B $6.1B $6.2B
Prepaid Expenses -- -- -- -- --
Other Current Assets $2.6B $4.5B $7.2B $6.7B $8.1B
Total Current Assets $26.6B $31.1B $33.6B $32B $40.4B
 
Property Plant And Equipment $16.9B $18.6B $20.4B $22.5B $23.4B
Long-Term Investments $1.4B $435M $984M $1.3B $575M
Goodwill $20.2B $18.9B $21.2B $21.2B $21.7B
Other Intangibles $16.7B $13.4B $21.4B $19.2B $17B
Other Long-Term Assets $8B $11.2B $9.6B $10.6B $14.4B
Total Assets $89.8B $93.5B $107.1B $106.7B $117.5B
 
Accounts Payable $3.7B $3.4B $3.4B $3.5B $3.6B
Accrued Expenses $11.7B $14.2B $14.2B $14.8B $16.5B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $20.4B $23.7B $23B $23.1B $29.6B
 
Long-Term Debt $26.3B $22.9B $28.5B $34B $35B
Capital Leases -- -- -- -- --
Total Liabilities $60.5B $57.6B $62.6B $65.4B $73B
 
Common Stock $1.8B $1.8B $1.8B $1.8B $1.8B
Other Common Equity Adj -$6.4B -$4.6B -$4.7B -$4.9B -$5.4B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $84M $69M $66M $54M $58M
Total Equity $29.3B $35.9B $44.5B $41.3B $44.6B
 
Total Liabilities and Equity $89.8B $93.5B $107.1B $106.7B $117.5B
Cash and Short Terms $7.4B $10B $11.2B $8.8B $14.6B
Total Debt $28.7B $26.4B $30.4B $34.9B $38.1B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $5.6B $4.5B $12.4B $14.5B $377M
Depreciation & Amoritzation $3.3B $3.5B $3.2B $3.9B $3.9B
Stock-Based Compensation $388M $441M $479M $541M $645M
Change in Accounts Receivable $92M -$1B -$2B -$644M -$1.1B
Change in Inventories -$473M -$895M -$674M -$161M -$816M
Cash From Operations $13.4B $10.3B $14.1B $19.1B $13B
 
Capital Expenditures $3.4B $4.4B $4.4B $4.4B $3.9B
Cash Acquisitions -$5B -$6.6B -$12.9B -$121M -$12B
Cash From Investing -$2.6B -$9.4B -$16.6B -$5B -$14.1B
 
Dividends Paid (Ex Special Dividend) -$5.7B -$6.2B -$6.6B -$7B -$7.4B
Special Dividend Paid
Long-Term Debt Issued $5B $4.4B $7.9B -- $5.9B
Long-Term Debt Repaid -- -$2B -$2.3B -$2.3B -$1.8B
Repurchase of Common Stock -$4.8B -$1.3B -$840M -- -$1.3B
Other Financing Activities $5M -$436M $8.7B -$240M -$328M
Cash From Financing -$8.9B -$2.8B $2.6B -$9.1B -$4.8B
 
Beginning Cash (CF) $8B $9.9B $8.2B $8.2B $12.8B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2B -$2B $147M $5B -$5.9B
Ending Cash (CF) $9.9B $8.2B $8.2B $12.8B $6.9B
 
Levered Free Cash Flow $10.1B $5.8B $9.7B $14.7B $9.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $2.3B $4.6B $3.3B $4.8B $3.2B
Depreciation & Amoritzation $807M $759M $959M $1B $1.2B
Stock-Based Compensation $116M $117M $139M $164M $195M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $2.2B $4.8B $5.6B $7.7B $9.3B
 
Capital Expenditures $1.4B $1.2B $1.1B $902M $783M
Cash Acquisitions -$586M $1M -$121M -- -$3.3B
Cash From Investing -$2.2B -$1.1B -$962M -$334M -$3.8B
 
Dividends Paid (Ex Special Dividend) -$1.5B -$1.6B -$1.7B -$1.9B -$2B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -$26M -- -- -$7M -$1M
Long-Term Debt Repaid -$2M -- -$1B -$1M --
Repurchase of Common Stock -- -$583M -- -$466M -$444M
Other Financing Activities -$28M -$59M $35M -$10M -$32M
Cash From Financing -$3.9B -$2.3B -$2.7B -$4.3B -$2.4B
 
Beginning Cash (CF) $11.1B $8.6B $9.8B $5.7B $11.4B
Foreign Exchange Rate Adjustment $87M -$46M -$412M -$157M $294M
Additions / Reductions -$3.8B $1.5B $1.9B $3.1B $3B
Ending Cash (CF) $7.4B $10B $11.3B $8.7B $14.7B
 
Levered Free Cash Flow $728M $3.6B $4.5B $6.8B $8.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $5.3B $5.9B $15.3B $4.6B $12.2B
Depreciation & Amoritzation $3.2B $3.3B $3.9B $3.8B $4.3B
Stock-Based Compensation $411M $472M $515M $623M $741M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $11B $13.1B $19.7B $17.2B $18.3B
 
Capital Expenditures $4B $4.7B $4.4B $4B $3.4B
Cash Acquisitions -$3.5B -$4.8B -$11.4B -$12B -$4.1B
Cash From Investing -$5.4B -$9.3B -$15.3B -$15.9B -$6.2B
 
Dividends Paid (Ex Special Dividend) -$6.1B -$6.5B -$6.9B -$7.3B -$7.7B
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -$2B -$1.2B -$3.4B -$1.8B -$754M
Repurchase of Common Stock -$2.3B -- -$18M -$953M -$1.2B
Other Financing Activities -$227M $8.8B -$205M -$393M -$333M
Cash From Financing -$6.2B -$1.2B -$2.4B -$4.1B -$6.3B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$602M $2.6B $2.1B -$2.8B $5.8B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $7B $8.4B $15.2B $13.2B $14.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $7.1B $8.5B $11.5B $1.6B $13.4B
Depreciation & Amoritzation $2.6B $2.4B $3B $2.9B $3.3B
Stock-Based Compensation $329M $360M $396M $478M $574M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $6.2B $9.1B $14.7B $12.8B $18B
 
Capital Expenditures $3B $3.2B $3.2B $2.9B $2.4B
Cash Acquisitions -$3.5B -$1.6B -$121M -$12B -$4.1B
Cash From Investing -$4.7B -$4.5B -$3.2B -$14.1B -$6.3B
 
Dividends Paid (Ex Special Dividend) -$4.7B -$5B -$5.3B -$5.6B -$5.9B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $4.4B -- -- $5.9B $3.6B
Long-Term Debt Repaid -$2B -$1.2B -$2.3B -$1.8B -$751M
Repurchase of Common Stock -$1.3B -$822M -- -$953M -$817M
Other Financing Activities -$472M $8.7B -$172M -$325M -$330M
Cash From Financing -$4.2B -$2.6B -$7.6B -$2.6B -$4B
 
Beginning Cash (CF) $28.5B $23.7B $26.5B $28.3B $24B
Foreign Exchange Rate Adjustment $89M -$65M -$776M -$163M $74M
Additions / Reductions -$2.6B $2B $3.9B -$3.9B $7.7B
Ending Cash (CF) $26B $25.6B $29.6B $24.2B $31.7B
 
Levered Free Cash Flow $3.2B $5.8B $11.4B $9.9B $15.6B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock